CEO and President of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Murray Richard /Ca/, sells 10,183 shares worth $68,837
According to Jounce Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:21 AM, company CEO and President, Murray Richard /Ca/ disclosed selling 10,183 shares at a cost of $6.76. At the time of this transaction (Jan 07), this trade was worth $68,837 in total. As of Jan 07, Murray Richard /Ca/ now owns 152,187 shares in total worth about $1,112,486.97.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) CEO and President, Murray Richard /Ca/, we have the following information:
- SEC Form 4 filing: Jan 08: Sold 11,816 shares at the rate of $7.00 per share. Total worth of this trade was $82,712. Total number of shares owned as of Jan 08 were 140,371
- SEC Form 4 filing: Jan 07: Sold 7,150 shares at the rate of $7.78 per share. Total worth of this trade was $55,627. Total number of shares owned as of Jan 07 were 87,360
- SEC Form 4 filing: Dec 23: Sold 40,000 shares at the rate of $8.37 per share. Total worth of this trade was $334,800. Total number of shares owned as of Dec 23 were 94,510
Posted by
George Daniels
on Monday January 11 2021, 9:45 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
